Table 2.
Patient | Nephropathy | eGFR at RTX initiation (mL/min/1.73 m2) | Cumulative RTX dose received | Associated immunosuppressive treatment | Infection | Time since the last RTX (months) | Gamma globulin levela | CD19 counta |
---|---|---|---|---|---|---|---|---|
1 | Lupus nephritis | 39.2 | 3400 | Steroids, plasmapheresis, AZA, MMF | Pneumonia | 13 | NA | 3 |
Septic shock S. aureus | 24 | 13.8 | NA | |||||
Septic shock P.aeruginosa leading to death | 25 | NA | NA | |||||
2 | MPGN | 29.1 | 4440 | Plasmapheresis, steroids | Pneumonia | 14 | NA | NA |
3 | MPGN | 46.2 | 4000 | Plasmapheresis, steroids | Pneumonia | 14 | 8.5 | 14 |
4 | MPGN | 41.2 | 2000 | Steroids | Mycobacterium avium cellulitis | 24 | 5.3 | 0 |
5 | MPGN | 24.9 | 2000 | Steroids | Cellulitis | 25 | NA | NA |
6 | MPGN | 22.2 | 3700 | None | Tuberculous lymphadenitis | 27.3 | 4.3 | 19 |
aLevels at the time of the infection.
NA, not available.